Ireland aims to win €1.25 bn – an average of €3M per week – over lifetime of 7 year programme.
Three Irish companies were successful in securing almost €5.33 million between them from a total budget of €99.96 million under phase 2 of the Horizon 2020 SME Instrument. Out of the 69 successful SMEs to achieve the Phase 2 funding, the 3 Irish companies were;Valitacell Ltd, Diania Ltd, and SwiftComply TopCo LtdIn this phase of the SME instrument, each project can receive up to €2.5 million, or €5 million for health projects, to finance innovation activities.
Dublin based Valitacell Ltd. develops biotechnology which allows companies to deliver faster and cheaper processing of bio-therapeutic drugs.
Galway based Diania Ltd is working on the commercialisation of advanced extrusion technologies through materials innovation to enhance the performance functionality of catheter based medical devices.
Dublin based SwiftComply TopCo has developed an innovative and exciting new approach to delivering and monitoring hospitality compliance, the Horizon 2020 funding will enable them to push this forward.
The funding allows the successful companies to invest in innovation activities such as demonstration, testing, piloting, scaling up and miniaturisation, in addition to developing a mature business plan for their product.
The companies will also benefit from 12 days of business coaching. Most projects are proposed by a single SME but some companies team-up to elaborate a project.
The next cut-off for applications from SMEs to Phase 2 of the Horizon 2020 SME Instrument is on 18/10/2017.
Contact firstname.lastname@example.org for further information.